drugset / Trial / NCT02414802

Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis

NCT02414802

Unknown 40 enrolled Xuzhou Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the novel aspiration thrombectomy device combined with catheter-directed thrombolysis is effective in the treatment of acute iliofemoral deep venous thrombosis (IF-DVT).

Timeline

Start
2014-12
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Urokinase Protein / enzyme biologic 100000 iu Other
Subject Urokinase Protein / enzyme biologic 1e+07 iu Other
Background low molecular weight heparin calcium Unknown 5000 iu Subcutaneous